Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase IIa trial of PB-2452 in healthy older adults

Trial Profile

A Phase IIa trial of PB-2452 in healthy older adults

Planning
Phase of Trial: Phase II

Latest Information Update: 28 Sep 2018

At a glance

  • Drugs PB 2452 (Primary)
  • Indications Haemorrhage
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 28 Sep 2018 New trial record
    • 24 Sep 2018 According to a PhaseBio Pharmaceuticals media release, the company plans to initiate this trial in healthy older adults the first half of 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top